Expand ACXP Menu
ACXP MENU

ACXP Latest Press Releases

-- April 23, 2024 --

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update PRNewswire 10:57 AM

-- March 18, 2024 --

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update PRNewswire 7:01 AM

-- March 4, 2024 --

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update PRNewswire 7:01 AM

-- February 27, 2024 --

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development PRNewswire 7:01 AM

-- February 23, 2024 --

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series Globe Newswire 9:30 AM

-- February 16, 2024 --

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT Globe Newswire 9:30 AM

-- February 2, 2024 --

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT Globe Newswire 9:30 AM

-- February 1, 2024 --

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT Globe Newswire 9:33 AM

-- January 29, 2024 --

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients PRNewswire 7:00 AM

-- January 26, 2024 --

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT Globe Newswire 10:55 AM

-- January 23, 2024 --

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024 PRNewswire 7:01 AM

-- January 19, 2024 --

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT Globe Newswire 9:30 AM

-- January 17, 2024 --

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients PRNewswire 7:01 AM

-- January 5, 2024 --

New to The Street Announces its Four Corporate Interviews, Episode 543, Airing on the Fox Business Network, Monday, January 8, 2024, at 10:30 PM PT Globe Newswire 9:30 AM

-- January 3, 2024 --

Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference PRNewswire 8:00 AM

-- December 11, 2023 --

Acurx Announces Positive Phase 2b Results Showing 100% of Patients Who Had Clinical Cure with Ibezapolstat Also Had Sustained Clinical Cure PRNewswire 7:01 AM

-- December 8, 2023 --

New to The Street TV Features Five Corporate Guest Interviews, Episode 537 Airs on the FOX Business Network, Monday, December 11, 2023, at 10:30 PM PT Globe Newswire 9:46 AM

-- December 7, 2023 --

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT Globe Newswire 9:20 AM

-- December 1, 2023 --

New to The Street Announces Five Corporate Interviews, Episode 535, Airing on the FOX Business Network on Monday, December 4, 2023, at 10:30 PM PT Globe Newswire 9:30 AM

-- November 24, 2023 --

New to The Street Announces its Five Business Guest Interviews, Episode 533, Airs on the FOX Business Network on Monday, November 27, 2023, at 10:30 PM PT Globe Newswire 9:30 AM